The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Abbvie; Astellas Pharma; Bayer; Janssen; Sanofi; TerSera; Tormar
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Janssen; Sanofi; TerSera; Tormar
Speakers' Bureau - Abbvie; Astellas Pharma; Bayer; Janssen; Sanofi; TerSera; Tormar
Research Funding - Sanofi
Other Relationship - Abbvie; Astellas Pharma; Bayer; Janssen; Sanofi; TerSera; Tormar
Biochemical disease control outcomes of stereotactic body radiation therapy (SBRT) or moderate hypo-fractionation (HFRT) for low- and intermediate-risk prostate cancer (PrCa): Retrospective analysis of 12 years of experience at two Canadian cancer centers.
 
Hsin-pei (Spencer) Hu
No Relationships to Disclose
 
Mohammad Gouran-Savadkoohi
No Relationships to Disclose
 
Gregory Anagnostopoulos
No Relationships to Disclose
 
Ian S. Dayes
Honoraria - Abbvie; Verity Pharmaceuticals
 
Adrian Ishkanian
No Relationships to Disclose
 
Abhirami Hallock
No Relationships to Disclose
 
Thomas B Corbett
No Relationships to Disclose
 
Himanshu Lukka
No Relationships to Disclose
 
Kimmen Quan
Other Relationship - Abbvie
 
Kara Schnarr
No Relationships to Disclose
 
David Cuthbert
No Relationships to Disclose
 
Mira Goldberg
No Relationships to Disclose
 
Theodoros Tsakiridis
Honoraria - AstraZeneca; Sanofi
Research Funding - Sanofi; Tolmar